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Background: Glucosidase II is an endoplasmic reticulum enzyme involved in quality control of glycoprotein folding.
Results: The structure of the lectin domain of GII was determined by NMR spectroscopy.
Conclusion: GII lectin domain structure contains a unique Trp residue critical for GII activity.
Significance: GII MRH domain structure is the first determined of an MRH domain present in a protein with enzymatic
activity.
Here we report for the first time the three-dimensional struc-
ture of a mannose 6-phosphate receptor homology (MRH)
domain present in a proteinwith enzymatic activity, glucosidase
II (GII). GII is involved in glycoprotein folding in the endoplas-
mic reticulum. GII removes the two innermost glucose residues
from theGlc3Man9GlcNAc2 transferred to nascent proteins and
the glucose added by UDP-Glc:glycoprotein glucosyltrans-
ferase. GII is composed of a catalytic GII subunit and a regula-
tory GII subunit. GII participates in the endoplasmic reticu-
lum localization of GII and mediates in vivo enhancement of
N-glycan trimming byGII through its C-terminalMRHdomain.
We determined the structure of a functional GIIMRHdomain
byNMR spectroscopy. It adopts a-barrel fold similar to that of
other MRH domains, but its binding pocket is the most shallow
known to date as it accommodates a single mannose residue. In
addition, we identified a conserved residue outside the binding
pocket (Trp-409) present in GII but not in other MRHs that
influences GII glucose trimming activity.
Mannose 6-phosphate receptor homology (MRH)3 domains
were first described in the two receptors responsible for deliv-
ering lysosomal enzymes from the transGolgi network to endo-
somal compartments in mammalian cells. In these mannose
6-phosphate receptors (MPRs), the MRH domains require the
presence ofmannose-linked phosphate groups inN-glycans for
binding, a structural feature not required by MRH domains
present in other proteins of the secretory pathway (1). Of the
known MRH domain-containing proteins, three are endoplas-
mic reticulum (ER)-resident proteins, OS-9 (Yos9p is the yeast
homolog of mammalian OS-9), Erlectin (also called XTP3-B),
and glucosidase II (GII) (2).
A quality control mechanism reliant on N-glycan structures
exists in the ER and ensures the correct folding of glycoproteins
within the secretory pathway of eukaryotic cells (see Fig. 1A) (3,
4). OS-9 and Erlectin are apparently involved in driving mis-
folded glycoproteins to proteasomal degradation. TheN-glycan
structural requirements for OS-9/Yos9p binding have been
studied in detail. Optimal recognition occurs in glycans lacking
residues i and k (see Fig. 1B), thus exposing an (1,6)-linked
mannose unit (residue j) (5–7). ER mannose removal (first
residue i followed by k) from the transferred glycan
(Glc3Man9GlcNAc2) is a relatively slow process compared with
deglucosylation and thus occurs mainly in slow folding/mis-
folded glycoproteins. Thus, the N-glycan binding specificity of
OS-9/Yos9p is particularly suited for the known function of this
protein. The binding specificity of theC-terminalMRHdomain
of Erlectin for Man9 has recently been reported, and it was
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proposed to serve as a negative regulator of ER-associated deg-
radation (8). In contrast to these two proteins, GII is an early
player in N-glycan processing as it removes the two inner glu-
coses from all transferred glycans (residues l andm; see Fig. 1B)
irrespective of the folding status of the protein. Removal of the
middle glucose (residuem) creates amonoglucosylated epitope
that is recognized by two unconventional chaperones, the lec-
tins calnexin and calreticulin. Their interactionswith glycopro-
teins enhance the folding efficiency of nascent polypeptides and
prevent the exit of folding intermediates and misfolded glyco-
proteins from the Golgi. Monoglucosylated N-glycans may be
also formed by the action of UDP-Glc:glycoprotein glucosyl-
transferase (UGGT) on fully deglucosylated glycans linked to
protein moieties not displaying their native structures (see Fig.
1A).
GII is a heterodimer composed of a catalytic GII subunit
and a regulatory GII subunit that contains an MRH domain
and in most species a KDEL-like ER retrieval sequence at its C
terminus (9, 10) (see Fig. 2A). Contrary to OS-9/Yos9p, maxi-
malN-glycan binding by GIIMRH domain requires the pres-
ence of mannose residue k of arm C (Fig. 1B). Furthermore, in
vivo and cell free assays show that a decrease inN-glycan man-
nose content results in lower GII enzymatic activity (11–15).
Not only does optimal GII deglucosylation activity require the
presence of the full complement of mannose units on nascent
glycoproteins but also the four conserved amino acids of the
GII subunit that are known to be essential for the ability of the
MRH domains of MPRs to bind mannose 6-phosphate (Man-
6-P)-containing lysosomal enzymes (15, 16) (Fig. 2B).
Why does GII differ from most other glycosidases for which
their maximal activity does not require the presence of a lectin-
like domain? We have shown previously that a decrease in
N-glycan mannose content sharply decreases in vivo GII activ-
ity without affecting the activity of UGGT, thereby prolonging
the half-life ofmonoglucosylated glycans produced by UGGT
(15). We speculate that ER mannosidase-mediated removal
of mannose units would result in an increased interaction of
slow folding/misfolded glycoproteins with the lectin chaper-
ones. This in turn would increase the chances for proper
folding of glycoproteins displaying an arduous folding proc-
ess and would result in a more stringent prevention of a
surreptitious exit of misfolded glycoproteins to the Golgi.
Therefore, the presence of the MRH domain converts GII
into a key regulator of the quality control mechanism of
glycoprotein folding. As the structure of OS-9 MRH domain
was recently determined (7), the significant difference
between its N-glycan binding specificity and that of GII
prompted us to determine the structure of GII MRH
domain. Here we report that GIIMRH domain folds into a
flattened -barrel similar to that of the MPRs and OS-9, but
its binding pocket is the most shallow solved to date. More-
over, we identified a residue (Trp-409) important for GII
activity and propose two models of how it could be influenc-
ing GII-mediated enhancement of GII activity.
EXPERIMENTAL PROCEDURES
Materials—Yeast extract and Bacto Peptone were from
Difco. Endo--N-acetylglucosaminidase H, porcine trypsin,
protease inhibitors, p-nitrophenyl -D-glucopyranoside
(pNPG), dithiothreitol (DTT), [15N]ammonium chloride,
[13C]glucose, Man-6-P, amino acids and supplements for cul-
turemedia, and protease inhibitors were fromSigma. [14C]Glu-
cose (301 Ci/mol) was from PerkinElmer Life Sciences.
N-Methyl-1-deoxynojirimycin was from Toronto Biochemi-
cals. Man1,2Man was obtained from Dextra Laboratories
(UK).
Strains and Media—Escherichia coli DH5 was used for
cloning purposes. Recombinant GII expression was per-
formed in SHuffle T7 Express lysY competentE. coli cells (BL21
C3030, New England Biolabs). Bacteria were grown at 37 °C in
LB medium (0.5% NaCl, 1% tryptone, 0.5% yeast extract) sup-
plemented with 200 g/ml ampicillin or 50 g/ml kanamycin
as needed. Schizosaccharomyces pombe cells were grown at
28 °C in rich YES medium (0.5% yeast extract, 3% glucose, and
75 g/liter adenine) or Edinburgh minimal medium (17, 18)
supplemented with adenine (75 g/liter), uracil (75 g/liter),
and/or leucine (250 g/liter) for selective growth. Thiamine
(0.5M) was added to pREP3x-GIIVDEL-transformed strains
to control expression levels from nmt1 promoter. S. pombe
strains used were Sp61II (GII: h, leu1–32, ade6-M210,
ade1, ura4-D18,gls2::ura4), ADmII (GII: h, leu1–32,
ade6-M210, ura4-D18, gls2::ura4), and SpADII
(GII: h, leu1–32, ade6-M216, ura4-D18 gls2::ura4,
gls2::ura4) as described (14).
Cloning and Expression of Recombinant Mature S. pombe
GII—Total RNA from S. pombe was obtained from exponen-
tially growing S. pombe wild-type cultures as described (19).
GII-coding DNA lacking the signal peptide (first 23 amino
acids) sequence was obtained by RT-PCR using the primers
B2sNde1 (5-GGAATTCCATATGGCAAATGACCTCCGT-
GGTG-3) and B2aNot1 (5-ATAGTTTAGCGGCCGCCT-
CATCGACAGATGATTC-3) that include NdeI and NotI
restriction sites (underlined) and a Superscript II reverse tran-
scriptase kit (Invitrogen). The PCR product was cloned in
NdeI/NotI sites of pET22b() vector as a C-terminal His6
fusion protein. The construction was transformed into BL21
3030 cells. After an overnight induction at 18 °C with 1.5 mM
isopropyl -D-thiogalactoside, bacteria were lysed by sonifica-
tion in binding buffer (20 mMTris-HCl, pH 7.9, 0.5 mMNaCl, 5
mM imidazole) with 0.5% (v/v) Triton X-100, 1 mg/ml
lysozyme, and protease inhibitors (100 M PMSF, 10 M leu-
peptin, 10M pepstatin, and 10M E64) and centrifuged for 20
min at 20,000 g. The protein was purified from the superna-
tant by immobilized metal ion affinity chromatography using a
column loaded with chelating Sepharose (GE Healthcare) pre-
charged with NiCl2. After extensive washes with binding buffer
followed with wash buffer (binding buffer plus 60 mM imidaz-
ole), elution was performed with elution buffer (binding buffer
plus 1 M imidazole). The protein was dialyzed against 50 mM
phosphate buffer, pH 7.4, 100 mM NaCl. The purification and
identity of the protein in the soluble fraction were verified by
10% SDS-polyacrylamide gel electrophoresis (PAGE) and
Western blot, respectively, with a mouse polyclonal anti-GII
S. pombe antibody (1:1000; Ref. 14) andmouse anti-His (1:1000;
Sigma).
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S. pombe Microsomal Fraction Preparations—S. pombe
microsomes were prepared from 250ml of exponentially grow-
ing cultures at an A600 of 2. Cells were harvested, washed with 5
mM NaN3, and broken by 10 repetitive cycles of 1-min vortexing
on ice with glass beads in 0.25 M sucrose, 20 mM imidazole, 5 mM
EDTA with protease inhibitors (100 M PMSF, 10 M L-1-tosyl-
amido-2-phenylethyl chloromethyl ketone, 10MN-p-tosyl-L-ly-
sine chloromethyl ketone, 10 M leupeptin, 10 M pepstatin, and
10 M E64), and the microsomal fraction was obtained as
described (10). Protein concentrations were determined using a
Bio-Rad protein assay as described by themanufacturer.
Protein Expression and Purification of S. pombe GII MRH
Domain—MRH GII cDNA encoding residues 357–450 was
cloned into a pQE30 vector modified to express the small ubiq-
FIGURE 1. Quality control of glycoprotein folding in the ER. A, schematic diagram of the glycan-processing steps during quality control of glycoprotein
folding in the ER. During N-glycosylation, a glycan (Glc3Man9GlcNAc2; B) is transferred to the Asn-X-Ser/Thr sequence of nascent proteins that are being
translocated into the ER. The sequential action of glucosidase I (GI) and GII produces monoglucosylated glycans able to interact with the lectin chaperones
calnexin (CNX) and/or calreticulin (CRT). This interaction facilitates both glycoprotein folding and interaction with the protein-disulfide isomerase ERp57, thus
preventing exit from the ER ofmisfoldedglycoproteins until proper folding is achieved (4, 45). The formation ofmonoglucosylated glycoproteins occurs either
by deglucosylation of the transferredN-glycan or by reglucosylation by UGGT. UGGT is a glycoprotein folding status sensor that transfers a glucose residue to
the Man9GlcNAc2 oligosaccharide of glycoproteins that have not yet acquired their native structure. Removal of mannose residues by -mannosidase(s)
generates a degradation signal onmisfolded/slow folding glycoproteins. OS-9 recognizesMan1,6Man1,6Man on the trimmedC arm via itsMRHdomain (7)
and facilitates entry of misfolded glycoproteins into the ER-associated degradation pathway where themisfolded glycoproteins exit the ER and are degraded
by the proteasome in the cytosol. SEC61, translocon;OST, oligosaccharyltransferase; ribbon diagram representing the crystal structure of calnexin is shown (Protein
Data Bank code 1JHN (53)); -MAN, -mannosidase; ribbon diagram of human OS-9 is shown (Protein Data Bank code 3AIH (7)). B, structure of the oligosaccharide
transferred to proteins during N-glycosylation. Lettering (a–n) follows the order of monosaccharide addition during the synthesis of Glc3Man9GlcNAc2-P-P-dolichol.
Glucosidase I (GI) removes residue n. GII removes residues l andm. UGGT adds residue l to residue g.
Structure of Glucosidase IIMRHDomain
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uitin-like modifier (SUMO) protein with an N-terminal hexa-
His tag and transformed into BL21(pREP4) cells. Constructs
containing the amino acid substitutions W409A and W409F
were generated using theQuikChange Lightning site-directed
mutagenesis kit (Stratagene). Cells were grown at 37 °C until an
OD of 0.7 at which time protein expression was induced by
the addition of 1 mM isopropyl -D-thiogalactoside. Cells were
harvested after 18 h. Protein was purified from insoluble inclu-
sion bodies usingmetal affinity chromatography. Refoldingwas
performed by diluting the protein into 100 mM Tris, pH 8.0, 10
mM cysteine, 0.5 mM cystine and stirring for 2 h at 22 °C. Fol-
lowing concentration, the SUMO-specific peptidaseULP-1was
added to remove the SUMO domain. The protein was dialyzed
and subjected to metal affinity chromatography to separate the
cleaved SUMO peptide from the MRH domain. Protein for
NMR analyses was then buffer-exchanged into a solution con-
taining 10mMdeuterated imidazole (pH 7.1) and 150mMNaCl.
The protein was further purified by size exclusion chromatog-
raphy using a Superdex 75 column. The concentration of the
purified protein was determined using the Bradford assay (Bio-
Rad) with bovine serum albumin (BSA) as the standard.
GIIMutagenesis and Expression in S. pombe—TheGateway
pDONR201 plasmid containing clone 26/D11 (S. pombe GII
subunit, which was obtained from RIKENDNA Bank (20)) was
used as the template for single amino acid PCR mutagenesis of
the GII MRH domain (W409A or W409F). The amplified
mutant DNA containing both GII and vector sequences was
phosphorylated, religated, and electroporated into DH5 cells.
The following primerswere used (mutagenic codons are under-
lined): W409F forward mutagenic primer 5-TTCAATGG-
TCCTCATAGATCTGCC-3 or W409A forward mutagenic
primer 5-GCTAATGGTCCTCATAGATCTGCC-3 was used
with W409 reverse primer 5-GCAACTTTGACCATTT-
TCATAC-3. Wild-type and mutant GII DNA clones were
transferred to the pREP1-ccdb2 Gateway-compatible S. pombe
destination expression vector (RIKEN DNA Bank) by the LR
recombination reaction (Invitrogen). S. pombe competent
GII cells were electroporatedwith the pREP1-GII episomal
constructs. The MRH binding pocket mutant constructs used
in this study (pREP1-GII Y462F and pREP1-GII E456Q)
were described in Stigliano et al. (14). Please note that the num-
bering in that case starts with the initial methionine, although
throughout this work the numbering corresponds to the
mature protein sequence.
Synthesis of Labeled N-Glycan Substrates—[14C-Glc]-
Glc1Man9GlcNAc was obtained by glucosylation of denatured
bovine thyroglobulin in the presence of UDP-[14C]glucose
(obtained as described (21)) and rat liver microsomes followed
by purification of endoglycosidase H-sensitive N-glycans as
described previously (22). Monoglucosylated glycans were sep-
arated from the unglucosylated compounds by two successive
paper chromatographic separations performed in 1-propanol/
nitromethane/H2O (5:2:4).
GII Activity Assays—GII activities using the small substrate
analog pNPG and labeledN-glycans as substrates were assayed
in S. pombemicrosomal fractions as described (14). Briefly GII
activity in GII mutants transformed with wild-type or
mutant regulatory subunits was assayed using 5 mM pNPG
as the substrate in 0.1 M HEPES buffer, pH 7.2 for 20 min
at 37 °C, and absorbance at 405 nm was measured, or
[14C-Glc]Glc1Man9GlcNAc was used as the substrate in 40mM
sodium phosphate buffer, pH 7.2 for 15 min at 30 °C. In the
latter case, glucosidase activity was determined as the percent-
age of total glucose released. Complementation assays between
GII and endogenous GII were performed using a mixture of
125 g of proteins from microsomes containing GII but not
GII (GII cells transformed with pREP3x-GIIVDEL as
described (14)) with 125 g of proteins from microsomes con-
tainingGII but notGII (GII S. pombe cells expressing only
endogenous GII). When assaying GII enhancement of GII
activity toward N-glycans of recombinant GII or MRH, the
microsomal source of GII subunit was replaced with 125 ng of
pure recombinant GII (this is in the linear range of activation;
data not shown) or with the indicatedMRH/GII or BSA/GII
mass ratios. Themixtures were preincubated for 30min at 4 °C
in the presence of 1% Triton X-100 and then assayed for GII
activity with [14C-Glc]Glc1Man9GlcNAc as described above.
Purification of Man9GlcNAc—Man9GlcNAc was obtained
from endo--N-acetylglucosaminidase H-digested denatured
soybean agglutinin purified from untoasted soybean meal by
affinity chromatography on acid-treated Sepharose 6B (23).
Soybean agglutinin (10mg) was denatured in 8 M urea for 5 h at
65 °C; dialyzed againstH2O; preincubated for 10min at 95 °C in
0.5% SDS, 0.1 M -mercaptoethanol in 50 mM triethylamine
acetate buffer, pH 5.5; and treated with 20 milliunits of endo-
-N-acetylglucosaminidase H (Sigma) for 16 h at 37 °C. Pro-
teins were precipitated with 66% methanol. To separate Man9
from remaining proteins, the supernatant was dried, resus-
pended in 10% ethanol, and resolved in a Superdex Peptide gel
filtration column (GE Healthcare) in 10% ethanol at 1 ml/min.
The glycan-containing fractions were detected using the phe-
nol-sulfuric acid assay (24), and protein elution was monitored
by absorbance at 280 nm.
Analysis of Glycans Synthesized in Vivo—To assess ERN-gly-
can composition, S. pombe cells in the exponential growth
phase expressing GII mutations were harvested, extensively
washed with 1% yeast nitrogen base medium without glucose,
and resuspended in 2 volumes (v/w) of the samemedium. Cells
(0.5 ml) were then preincubated for 5 min in 5 mM DTT and
pulsed for 15 min with 5 mM glucose containing 150 Ci of
[14C]glucose (300 Ci/mol). Further details on the labeling pro-
cedure and the preparation of whole cell endo--N-acetylglu-
cosaminidase H-sensitive N-glycans have been described pre-
viously (25). Glycans were separated by paper chromatography
using Whatman 1 papers and 1-propanol/nitromethane/H2O
(5:2:4) as solvent, and the peaks were identified by standards
run in parallel. To improve the resolution, the identified glycans
were eluted from paper and resolved by HPLC using a TSKgel
Amide-80 column (4.6-mm inner diameter  25 cm; Tosoh)
with a mobile phase of H2O/CH3CN in a linear gradient from
35:65 to 55:45 over 65 min and a flow rate of 0.75 ml/min at
room temperature. Because of slight variations in retention
times among runs, the positions of the peaks in paper chroma-
tography and not the retention times from HPLC were used to
identify glycans.
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Surface Plasmon Resonance (SPR) Analyses—Biosensor stud-
ies were carried out as described previously (26). All SPR mea-
surements were performed at 25 °C using a BIAcore 3000 instru-
ment (GE Healthcare). Purified protein (acid -glucosidase
(GAA),GAAphosphomonoester, orGAAphosphodiester) was
immobilized on a CM5 sensor chip (GE Healthcare) following
activation of the surface using 1-ethyl-3-(3-dimethylaminopro-
pyl)carbodiimide and N-hydroxysuccinimide. The proteins
were injected onto the activated dextran surface at a concentra-
tion of 10–20 g/ml in 10 mM sodium acetate buffer, pH 5.0
(GAA phosphomonoester), pH 4.5 (GAA phosphodiester), or
pH 5.0 (GAA) using immobilization buffer (10 mM MES, pH
6.5, 150mMNaCl, 0.005% (v/v) P20) as the running buffer. After
coupling, unreacted N-hydroxysuccinimide ester groups were
blocked with ethanolamine. The reference surface was treated
in the same way except that protein was omitted. To assess
binding affinities, samples of purified proteins were prepared in
running buffer (50 mM imidazole, pH 7.4, 150 mM NaCl) and
injected in a volume of 80 l over the coupled and reference
flow cells at a flow rate of 40 l/min. After 2 min, the solutions
containing the purified proteins were replaced with buffer, and
the complexes were allowed to dissociate for 3 min. The sensor
chip surface was regenerated with a 10-l injection of 10 mM
HCl at a flow rate of 10 l/min. The surface was allowed to
re-equilibrate in running buffer for 1 min prior to subsequent
injections. The response at equilibrium (Req) for each concen-
tration of protein was determined by averaging the response
over a 10-s period within the steady state region of the sensor-
gram using the BIAevaluation software package (version 4.0.1).
The response at equilibrium (Req) was plotted versus the con-
centration of protein and fitted by nonlinear regression to a
one-site saturation binding model using the equation y 
(Rmax [MPR])/(Kd [MPR]) (SigmaPlot version 10.0, Systat
Software, Inc.). All response data were double referenced (27)
where controls for the contribution of the change in refractive
index were performed in parallel with flow cells derivatized in
the absence of protein and subtracted from all binding
sensorgrams.
Data Collection and Structure Determination by Heteronu-
clear NMR Spectroscopy—NMR spectra were acquired at 25 °C
on a Bruker 600-MHz spectrometer equipped with a triple res-
onance CryoProbeTM. Spectral data were processed using
NMRPipe (28) and visualized using XEASY (29). Complete 1H,
15N, and 13C resonance assignments for GII MRH domain
were obtained in a semiautomated manner using peak lists
from three-dimensional HNCO, HNCOCA, HNCOCACB,
HNCA, HNCACB, HNCACO, CCONH, HBHACONH,
HCCONH, and HCCH total correlation spectroscopy and 13C
(aromatic)-edited NOESY-HSQC spectra and the assignment
programGARANT (30). Automated assignments were verified
and completed by manual inspection. Structures of the GII
MRH domain were calculated using distance constraints
derived from three-dimensional 15N-edited NOESY-HSQC
and 13C-edited NOESY-HSQC spectra (mix  80 ms). Back-
bone  and  dihedral angle constraints were generated using
TALOS (31) and the secondary shifts of the 1H, 13C, 13C,
13C, and 15N nuclei. Initial structures were generated in an
automated manner using the NOEASSIGN module of the tor-
sion angle dynamics program CYANA (32). Initial structures
underwent iterative rounds ofmanual refinement inCYANA to
eliminate constraint violations. The top 20 CYANA conform-
erswith the lowest target functionwere further refined using an
Xplor-NIH (33) molecular dynamics protocol in explicit sol-
vent (34). The structural statistics are listed in Table 1.
Determination of Binding Affinities by Heteronuclear NMR
Spectroscopy—NMR studies in which 15N-labeled GII MRH
domain was titrated with increasing concentrations of ligand
(Man-6-P (Sigma), Man1,2Man (Dextra Laboratories), or
Man9GlcNAc purified from soybean agglutinin were carried
out as described previously (35).
Antibodies and Immunodetection—Microsomal S. pombe
proteins (250 g) were resolved in a 10% SDS-PAGE, electro-
blotted to ImmobilonP membranes (Millipore), and incubated
with mouse anti-S. pombe GII or mouse anti-S. pombe GII
antibodies. Immunodetection was carried out using enhanced
chemiluminescence (West Pico SuperSignal Chemilumines-
cent Substrate, Thermo Scientific) with horseradish peroxi-
dase-conjugated IgGs (Sigma) as described (15).
RESULTS ANDDISCUSSION
Full Functionality of the E. coli-expressed S. pombe GII
MRHDomain—Wehave previously shown that, in the absence
of GII, GII folds into an active subunit that can hydrolyze the
small substrate analog pNPG but is unable to efficiently hydro-
lyze glucose from N-glycans in vivo or in vitro (14). We devel-
oped a complementation assay and showed that a mixture of
microsomes derived frommutant S. pombe cells devoid of GII
or GII subunits could partially restore the level of GII deglu-
cosylation of Glc1Man9GlcNAc observed in microsomes from
wild-type cells (14). Using this assay, addition of recombinant
GII dramatically increased the Glc trimming from
Glc1Man9GlcNAc of S. pombe microsomes lacking GII (Fig.
3A). To determine whether the isolated MRH domain of S.
pombeGII (amino acids 357–450; Fig. 2) was functional when
expressed in E. coli, we used the same assay. Addition of up to
50 times more molar amounts of the recombinant GIIMRH
domain (compared with full-length GII) to microsomes con-
taining only GII subunits did not enhance GII enzymatic
activity (Fig. 3A). This result was expected as theMRH domain
lacks the portion of the GII subunit responsible for the inter-
action betweenGII andGII subunits (GIIG2Bdomain; Fig.
2A) (15, 16). However, addition of GIIMRHdomain inhibited
GII activity in mixtures of microsomes containing GII plus
GII subunits in a dose-dependent manner (Fig. 3B), thus
strongly suggesting that the recombinant GII MRH domain
was sequestering the high mannose glycan portion of the sub-
strate. In contrast, BSA had no effect (Fig. 3B).
To directly assess the ability of GII MRH domain to bind
high mannose-type glycans, SPR experiments were conducted
inwhich a glycoprotein, GAA,was immobilized andGIIMRH
domain was flowed over the surface of the sensor chip. The
immobilized recombinantGAAcontains exclusively highman-
nose-type glycans with 8.35 mannose residues on average per
glycan (36). In these studies, we used a robust E. coli expression
system in which recombinant GIIMRH domain was purified
from insoluble inclusion bodies and refolded. The results dem-
Structure of Glucosidase IIMRHDomain
16464 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 23•JUNE 7, 2013
 by guest on July 6, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
onstrate that the MRH domain binds high mannose-type gly-
cans with an estimated Kd of 120 M (Fig. 4A). The affinity
measured by SPR, although lower, is comparable with the affin-
ities (Kd  20–80 M) determined for a tetrameric form of
the human GII MRH domain using frontal affinity chroma-
tography and 2-aminopyridine-labeled glycans (13). Differ-
ences may be due to differences between species, between sub-
strates, in the analytical methods used for measurements, and
between monomeric and tetrameric avidities of the protein
preparations. Taken together, these results demonstrate that
the refolded recombinant S. pombeGIIMRH domain is func-
tional in binding high mannose N-glycans and thus is suitable
for structural analyses (13).
GII Lectin Domain Adopts the Conserved MRH Fold—The
300-kDa cation-independent MPR (CI-MPR) contains 15
extracellularMRHdomains, three of which bind phosphoman-
nosyl residues (domains 3, 5, and 9), whereas the smaller cation-
dependent MPR (CD-MPR) contains a single MRH domain.
Our crystal/solution structures of the CD-MPR and domains
1–3 and domain 5 of the CI-MPR have been determined in the
FIGURE 2.Comparisonof glycan-bindingMRHdomains fromGII, CD-MPR, CI-MPR, andOS-9.A, schematic representation of the domain organization of
S. pombe GII. The mature polypeptide lacking the predicted 23-residue signal sequence is shown. B, structure-based sequence alignment of MRH domains
from S. pombe GII, bovine CD-MPR, domains 3 and 5 of the bovine CI-MPR, and human OS-9. The secondary structural elements of GII with arrows
representing -strands and loops A–D are indicated. In contrast to GII and OS-9, the MPRs contain additional elements at their N terminus: domains 3 and 5
of theCI-MPRcontain two-strands,whereas theCD-MPRcontains a single-helix (seeFig. 5D). Cysteine residues are shaded in yellow. Residues that arewithin
hydrogen-bondingdistanceof themannose ring asdeterminedby the crystal structureofOS-9 (ProteinData Bank code3AIH), domains 1–3 (ProteinDataBank
code 1SZ0) of the CI-MPR, and the CD-MPR (Protein Data Bank code 1C39) and the NMR solution structure of domain 5 (Protein Data Bank code 2KVA) of the
CI-MPR and have been shown to be essential for Man-6-P binding by mutagenesis studies (i.e. Gln, Arg, Glu, and Tyr) are shaded in red. Trp-118 of OS-9 that
along with Trp-117 is hypothesized to be involved in Man1,6Man linkage recognition (7) is shaded in cyan. The corresponding tyrosine residue in GII,
domains 3 (d3) and 5 (d5) of the CI-MPR, and the CD-MPR are boxed in cyan. Trp-409 of GII is boxed in green.
FIGURE 3. TheMRHdomain of GII represents a fully functional glycan binding unit. TheMRH construct was expressed as a SUMO fusion protein in E. coli
and purified and refolded from inclusion bodies prior to proteolytic removal of the SUMO peptide. Mature GII was expressed in an E. coli strain that allows
disulfide bridge formation (BL21 C3030) as a soluble His6-tagged fusion protein (A and B). A, MRH alone is unable to replace GII-mediated restoration of
glucosidase activity. A source of GII (125g ofmicrosomes fromGII S. pombe cells transformedwith pGIIVDEL) was incubated alone (GII), with 125 ng
of recombinantGII (GIIGII), orwith1.25gof recombinantMRH (GIIMRH). GII activitywasmeasuredas theamountofglucose releasedafter a 15-min
incubationwith [14C-Glc]Glc1Man9GlcNAc (14). Theamountofglucose released in theGIIGIIconditionwassetat100%.B,MRHcompeteswithGII forbinding
tohighmannoseN-glycans.Microsomes fromGIIS.pombecells transformedwithpGIIVDELwere incubatedas inAwith150ngof recombinantGII (GIIGII)
or alongwith the indicatedamountsofMRH/GIIorBSA/GII ratios. Theamountofglucose released in theGIIGIIconditionwas setat100%.Errorbars represent
S.D.
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presence of a carbohydrate ligand (35, 37). These structures
allowed us to identify four conserved residues (Gln, Arg, Glu,
and Tyr), which interact with the 2-, 3-, and 4-hydroxyl groups
of themannose ring, that are essential forMan-6-P recognition
by theMRHdomains ofMPRs. These four residues, which form
the binding pocket, are also conserved in the GII MRH
domain (Fig. 2B). Mutagenesis of the analogous residues in S.
pombe GII MRH domain abolished the ability of GII to
enhance glycan trimming byGII in live cells (14). Previous stud-
ies showed that the GII MRH domain recognizes mannose
residues in the B and/or C arms of N-glycans as the absence of
these mannose residues in the glycan prevents trimming of the
glucose in arm A by GII both in vitro and in living cells (11–13,
15, 38). The differences in substrate specificity between this ER
glycoprotein folding quality control enzyme andOS-9, a recep-
tor involved in ER-associated degradation, prompted us to
obtain the solution structure of the isolated GIIMRHdomain
from S. pombe using three-dimensionalNMR techniques. Sam-
ple conditions were optimized as described under “Experimen-
tal Procedures” to obtain high quality spectra of 15N/13C-la-
beled recombinant GIIMRH domain at pH 7.2 (Table 1).
S. pombeGII is the shortest (89 residues; Fig. 2) of theMRH
domain structures that have been determined to date (eight of
the 15 MRH domains of CI-MPR (35, 39–41), CD-MPR (42),
and OS-9 (7)). GII MRH domain folds into a flattened nine-
stranded -barrel comprising two antiparallel -sheets ori-
ented orthogonally over one another (Fig. 5, A–C). This struc-
ture is similar to the structures reported for the MRH domains
of the MPRs and OS-9 with the overall fold of GII MRH
domain beingmost similar to that ofOS-9 (r.m.s.d. 1.32Å; 85
C atoms) (Fig. 5D). Both OS-9 and GII adopt a compact
-barrel structure due to their lack of20 amino acids present
at the N terminus of the CD-MPR and CI-MPRMRH domains
that form either an -helix or two to three short -strands,
respectively. However, S. pombe GII MRH domain loops A
and B as well as -strands 4/5 and 6 are significantly shorter
than those in OS-9 (Fig. 5D). Additionally, S. pombeGIIMRH
domain contains only four cysteine residues in contrast to the
six (CD-MPR, CI-MPR domain 5, and OS-9) or eight (domains
3 and 9 of the CI-MPR) cysteine residues found in the other
glycan-binding MRH domains. The absence of the N-terminal
disulfide bond in S. pombe GIIMRH domain that is found in
other MRH domains as well as other species of GII does not
appear to affect the overall fold of the domain. The structural
stability provided by the N-terminal disulfide bond may be
FIGURE 4. SPR analyses of GII MRH domain binding to a glycoprotein,
GAA. Purified GIIMRH domain was flowed over the surface of a CM5 sensor
chip immobilized with GAA containing high mannose N-glycans (A), high
mannose N-glycans with phosphomonoesters (B), or high mannose N-gly-
cans with phosphodiesters (C). The response at equilibrium (Req) to the GAA
surfaces is plotted versus the concentration of protein (0, 5, 10, 20, 40, 80, 120,
and 160M) and fitted as described previously (35). GAA contains exclusively
high mannose-type glycans with 8.35 mannose residues on average per gly-
can and either 0.25 mol of Man-6-P/mol of glycan (phosphomonoester) or
GlcNAc-modifiedglycan (phosphodiester) (36). Themean andS.D. from three
independent analyses are as follows for the highmannose, phosphomonoes-
ter, and phosphodiester surfaces, respectively: wild type, 121 35, 115 16,
and 111  28 M; W409A, 294  219, 203  44, and 395  44 M; W409F,
193 72, 176 35, and 212 73 M.
TABLE 1
Refinement statistics for the GII MRH domain NMR ensemble of 20
structures
r.m.s., root mean square.
Experimental constraints
Distance constraints
Long 737
Medium (1	 (i j)5) 260
Sequential ((i j) 1) 465
Intraresidue (i j) 338
Total 1,800
Dihedral angle constraints ( and ) 130
Average atomic r.m.s.d. to the mean structure (Å)
Residues 358–450
Backbone (C, C, N) 0.39 0.06
Heavy atoms 0.83 0.09
Deviations from idealized covalent geometry
Bond length r.m.s.d. (Å) 0.019
Torsion angle violation r.m.s.d. (°) 1.4
Constraint violations
NOE distance
Number
0.5 Å 0.0 0
r.m.s.d. (Å) 0.020 0.001
Torsion angle violations
Number
5° 0.0 0
r.m.s.d. (°) 0.734 0.089
WHATCHECK quality indicators
Z-score 0.34 0.15
r.m.s. Z-score
Bond lengths 0.85 0.02
Bond angles 0.67 0.02
Bumps 0.0 0
Lennard-Jones energya (kJ mol1) 2,261 47
Ramachandran statistics (% of all residues)
Most favored 83.5 1.8
Additionally allowed 13.7 1.7
Generously allowed 1.3 0.9
Disallowed 1.5 0.5
a Nonbonded energy was calculated in Xplor-NIH.
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replaced in S. pombe GII MRH domain with electrostatic
interactions betweenGlu-364 and Lys-366 and Lys-375 located
on strands 1 and 2, respectively (Fig. 5D).
The dynamic nature of the GIIMRHdomain was evaluated
by a comparison of r.m.s.d. values calculated between corre-
sponding C atoms for eachmember of the structure ensemble
and 15N-1H heteronuclear NOE experiments. Unlike domain 5
of the CI-MPR, which showed overall greater mobility as
assessed by 15N-1H heteronuclear NOE values (35), the com-
pact nature of GII MRH domain with shortened loops
between strands 1 and 2 and strands 4/5 and 6 coupled with the
presence of a disulfide tethering loops C and D together results
in comparably lower flexibility in themolecule in the absence of
ligand and r.m.s.d. values more similar to domain 5 of CI-MPR
FIGURE 5. Solution structure of GIIMRH domain and comparison with solved structures of other MRH domain-containing proteins. A, superimposi-
tion of the backbone atoms of the 20 lowest energy structures of GII MRH domain ensemble. N and C termini are boxed, and loops C and D are labeled.
B, ribbon diagram of the representative conformer (derived from an ensemble of 20 conformers) of GIIMRH domain in a ligand-free state is shown (Protein
DataBank code2LVX).-Strands arenumbered from theN to theC terminus, and loopsA throughDare labeled.Disulfidebonds are shown in yellow.C, close-up
view of the GIIMRH domain binding pocket. The backbone atoms of the lowest energy conformer are represented by the orange ribbon, and the side chains
of the ensemble members are shown as lines. The essential residues within the proposed binding pocket are shown in green, whereas Trp-409, which shows
highmobility, is shown in blue. Loops A, B, C, andD are labeled.D, comparison of GIIMRHdomainwith solved structures ofMRHdomain-containing proteins.
Upper panel, ribbon diagram of the representative conformer (derived from an ensemble of 20 conformers) of GIIMRHdomain in a ligand-free state (orange;
Protein Data Bank code 2LVX) and of the MRH domains of CD-MPR (pink; Protein Data Bank code 1C39), domain 3 of CI-MPR (green; Protein Data Bank code
1SZ0; Man-6-P), domain 5 of CI-MPR (blue; Protein Data Bank code 2KVB), and OS-9 (gray; Protein Data Bank code 3AIH). Disulfide bonds are shown in yellow.
Below the ribbon diagram of GIIMRHdomain is a close-up view of the N-terminal region inwhich electrostatic interactions replace a disulfide bond found in
theotherMRHdomains. Thedistance in angstromsamong the side chainsofGlu-364, Lys-366, andLys-375 is shown. FiguresweregeneratedusingPyMOL (54).
Lower panel, superimposition of the structure of the GIIMRH domain with each of the structures shown in the upper panel. CD-MPR aligns over 90 C atoms
with an overall r.m.s.d. of 1.99 Å. CI-MPR domain 3 aligns over 88 C atomswith an overall r.m.s.d. of 1.98 Å. CI-MPR domain 5 aligns over 89 C atomswith an
overall r.m.s.d. of 2.00 Å. OS-9 aligns over 85 C atoms with an overall r.m.s.d. of 1.32 Å. E, backbone (C) r.m.s.d. values of the ensemble for GIIMRH domain
(solid line) and 15N-1H heteronuclear NOE values (bars) are plotted as a function of amino acid sequence. Secondary structural elements are also shown. The
N-terminal five residues and Gly-397 were unassigned.
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in the ligand-bound state. These results demonstrate that the
structure of GII MRH domain is relatively constrained with
the exception of residues in loops C and D (Fig. 5, A, C, and E).
Binding Pocket and Specificity of GII MRH Domain—To
map the binding pocket of GII MRH domain with carbohy-
drates, increasing amounts of the disaccharide Man1,2Man,
the monosaccharide Man-6-P or glucose 6-phosphate (Glc-6-
P), or the glycan Man9GlcNAc were added to 13C/15N-labeled
sample, and changes in chemical shifts of amide groups located
in either backbone or side chains weremonitored. These ligand
titrations were also used to (i) determine whether pure glycan
and simple carbohydrate molecules bound specifically to the
conserved MRH domain recognition site and (ii) test the
hypothesis that the GII MRH domain selectively recognizes
mannose in contrast to glucose. An overlay of spectra acquired
in the presence of increasing concentrations of Man1,2Man,
Man-6-P, orMan9GlcNAc demonstrated progressive chemical
shift changes for residues either within or adjacent to the pro-
posed binding pocket (Fig. 6A). The weighted changes in com-
bined 1H/15N chemical shift perturbations were used to deter-
mine relative binding affinities for Man1,2Man (Kd 65 3
mM), Man-6-P (Kd  77  7 mM), and Man9GlcNAc (Kd 
2.6 0.4 mM) (Figs. 7, A–C). These results show a significantly
higher relative affinity (25-fold) for the larger glycan than for
the disaccharide. The ability to recognize both mannose and
Man-6-P suggests that substitution at the 6-position (i.e.
hydroxyl or phosphate) does not constitute amajor recognition
determinant for GIIMRH domain. This hypothesis is further
validated by SPR analyses show that Kd values for GII MRH
domain interacting with an immobilized glycoprotein bearing
highmannose (Fig. 4A), phosphomonoesters (Fig. 4B), or phos-
phodiesters with aGlcNAc on the 6-OH group of themannose
(Fig. 4C) are similar. Thus, the GIIMRH domain differs from
the P-type lectin MRH domains of the MPRs that exhibit a
preference to bind either phosphate on the 6-hydroxyl of man-
nose (domain 3 of the CI-MPR and CD-MPR) or a phosphodi-
ester (domain 5 of the CI-MPR) (36) and from human OS-9,
which binds mannose but not Man-6-P (43).
To probe whether the GIIMRH domain can recognize glu-
cose, 15N-1HHSQC collected in the presence of Glc-6-P, which
differs from Man-6-P only in the positioning of the 2-OH
group, produced chemical shift perturbations localized to the
same regions as Man-6-P although to a significantly lower
extent (Figs. 6B and 7D). These weak interactions observed
withGlc-6-P demonstrate that the axial 2-OHpresent inman-
nose is a key recognition determinant for the GII MRH
FIGURE 6. HSQC spectra of GIIMRH domain with Man1,2Man, Man-6-P, Man9GlcNAc, or Glc-6-P. Selected regions of
15N-1H HSQC spectra GIIMRH
domain collectedwith increasing amounts of disaccharideMan1,2Man (top), themonosaccharideMan-6-P (middle), and the glycanMan9GlcNAc (bottom) (A)
or Glc-6-P (B) are shown. The spectrumof 0.1mMGIIMRHdomainwas collected in the presence of ligands in concentrations ranging from0 to 400mM added
in seven aliquots of Man1,2Man and Man-6-P, in three aliquots (0.4, 0.8, and 1.6 mM) of Man9GlcNAc, or a single aliquot of 200 mM for Glc-6-P (color code:
orange, 0 mM; cyan, highest concentration reached with each ligand; from gray to black, intermediate concentrations).
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domain. Although Kd values of 65–77mM for the monosaccha-
ride Man-6-P and disaccharide Man1,2Man may not equate
to the binding interactions occurring between GII and its het-
erogeneous population of N-glycan-containing substrates in
the ER, the results demonstrate that GIIMRH domain inter-
acts preferentially with mannose. Taken together, the observa-
tion that the affinity for the monosaccharide Man-6-P and the
disaccharide Man1,2Man are similar along with the ability of
Glc-6-P to cause specific but very low chemical shift perturba-
tions supports the structural findings that GIIMRH domain
has a shallow binding pocket (see below) that accommodates
preferentially a single mannose residue. From a functional
standpoint, the inability of GII MRH domain to efficiently
recognize glucose eliminates the potential for the -subunit to
compete with the catalytic -subunit of GII for glucose present
in arm A of the N-glycan.
Mannose Binding Pocket—GII MRH domain contains the
four residues (Gln-384, Arg-414, Glu-433, and Tyr-439) known
to be essential for Man-6-P binding by the MPRs (Fig. 2B), and
mutational studies support their involvement in GII activity
(13, 14). To evaluate the role these residues play in carbohy-
drate binding, measurements of weighted differences in com-
FIGURE 7. Interaction ofGIIMRHdomainwithMan1,2Man,Man-6-P,Man9GlcNAc, orGlc-6-P. The spectrumof 0.1mMGIIMRHdomainwas collected
in the presence of ligands and is shown in Fig. 6. 15N-1H chemical shift perturbations for Man1,2Man (A), Man-6-P (B), Man9GlcNAc (C), or Glc-6-P (D) were
plotted against the residue number of GIIMRH domain (left panels). Secondary structural elements are listed below the sequence numbers. Missing values
correspond to proline residues or residues not observed in the 15N-1H HSQC spectra. Middle panels depict chemical shift mapping on the GIIMRH domain
structure. The molecular surface highlighted in red corresponds to amino acids with the largest chemical shift perturbations (
1), whereas those colored in
cyan representmoderate perturbations (0.5). Right panels, chemical shift differences for the eight selected residues (labeled inA) were calculated as [(5
NH)2N]1/2. Representative curves for four of the eight residuesmonitored for theMan1,2Man andMan-6-P titrations and curves for the three residues
monitored for the Man9GlcNAc titration are shown. Dissociation constants (Kd) were determined from monitoring changes in the chemical shift of the eight
selected residues as described under “Experimental Procedures.”
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bined 1H/15N chemical shift perturbations with increasing
amounts of ligand were used to map the location of the
Man1,2Man, Man-6-P, and Man9GlcNAc (Fig. 7, A–C) bind-
ing site to the surface ofGIIMRHdomain. The greatest chem-
ical shift perturbations of the ligands map to an area (loops C
and D) corresponding to the known carbohydrate binding sites
of CD-MPR, of domains 3 and 5 of the CI-MPR, and of OS-9.
Although chemical shift perturbations were observed for resi-
dues in the proposed binding pocket, two of the essential ligand
binding residues, Gln-384 and Tyr-439, did not show signifi-
cant changes in chemical shift in the presence of ligand (Fig. 7).
We postulate from the structure that the amide protons are
unable to shift due to extensive hydrogen bonding with neigh-
boring atoms due to their location in -strands that are part of
the two -sheets. Residues in loop A experienced slightly
greater chemical shift differences in the presence of the larger
ligands: a stronger chemical shift perturbation at Gly-370 and
additional perturbations for Tyr-372 and Thr-373 were
observed (Fig. 7, A–C). However, the striking similarity of the
chemical shift mapping between the disaccharide and the mono-
saccharide coupled with their similar affinities supports the
lack of an extended binding pocket. This notion is further sup-
ported by the observation that the branchedMan9GlcNAc gly-
can, which exhibited25-fold higher affinity than Man-6-P or
Man1,2Man, failed to produce additional measurable chemi-
cal shift perturbations at the highest concentration used (Fig.
7). Although these structural analyses failed to identify addi-
tional protein contacts to explain the increased affinity
observed for the Man9GlcNAc glycan compared with the
smaller ligands, the longer glycan may have constrained the
terminal and penultimate mannose into an optimal conforma-
tion for binding. Furthermore, the observed 20-fold higher
affinity of GII MRH domain for a glycoprotein bearing high
mannose-type N-glycans compared with a glycan free in solu-
tion (Kd  120 M (Fig. 4A) versus Kd  2.6  0.4 mM (Fig.
7C); SPR data were obtained with glycoproteins, whereas NMR
data were obtained using free glycans) may be the result of
protein-induced restrictions that increase the percentage of
N-linked glycans in the optimal conformation for binding
and/or of differences in the principles of the methods used to
estimate affinities.
The lumen of the ER is a crowded environment with protein
concentrations up to 200–300mg/ml (44). Given the high sub-
strate concentration for the ER quality control machinery in
which transient interactions occur, it is reasonable to expect
that the affinities of ERMRH domains for glycoproteins in this
environment would not be as high as those of the Golgi MRH
domains inwhich theMan-6-P receptorsmust capture the very
low abundance of lysosomal enzymes for transportation to late
endosomes. The limited interactions with mannose and the
failure of eitherMan9GlcNAc or a disaccharide to produce sub-
millimolar binding affinities are likely a direct consequence of
the shallowness of this binding pocket relative to the other
MRH binding pockets solved to date (CD-MPR, domains 3 and
5 of CI-MPR, and OS-9) (Fig. 8). In S. pombe, this shallowman-
nose binding region is due to the dramatically shortened loop B
relative to other species and the positioning of loop C more
distally from the essential residues in the pocket, thereby allow-
ing the binding site to accommodate mannose modified at the
6-hydroxyl (i.e. phosphate and GlcNAc) (Figs. 5 and 8). Nota-
bly, the four residues considered essential for mannose binding
(Gln-384, Arg-414, Glu-433, and Tyr-439) overlay well with
those in the other four MRH domains (Fig. 8). Because the
ligand-bound crystal structures of domain 3 of the CI-MPR,
OS-9, and the CD-MPR demonstrate directly that the common
positioning of these four essential residues results in a nearly
identical positioning of the mannose ring within the binding
pocket, we predict that the mode of mannose binding by the
GIIMRH domain to these four residues will be essentially the
same.
Although the four mannose-interacting residues are con-
served among these MRH domains, other structural features
must exist to explain the different preferences displayed by
these proteins for high mannose-type glycans (45). For exam-
ple, OS-9 contains a double tryptophan motif that is proposed
to determine the 1,6-linkage specificity of OS-9 (7). These
residues form an extended surface to accommodate the penul-
timate and prepenultimate mannose residues of one arm of the
glycan (see Fig. 8) (7). In contrast, GIIMRH domain contains
a conserved tyrosine residue (Tyr-372; strand 2) as observed
in the MPRs (Figs. 2B, cyan, and 8). This tyrosine has been
proposed by Satoh et al. (7) to be the residue responsible for
conveying 1,2-linkage specificity by the MPRs. However, we
have crystallized domain 3 of the CI-MPR with aMan1,3Man
in the binding pocket (39), suggesting that this tyrosine (Tyr-
324) in domain 3 is not involved in specifying a linkage prefer-
ence for 1,2-containing ligands. Furthermore, the side chain
of Tyr-372 of the GIIMRH domain, unlike that of the MPRs,
is oriented 90° away from the binding pocket such that the
hydroxyl group is unable to interact with the glycosidic linkage
of the ligand (Fig. 8). The significant number of NOE con-
straints for this residue along with the rest of the molecule
(average of 21 NOE constraints per residue) further validates
the positioning of the side chain of Tyr-372 in the GIIMRH
domain structure determined in the absence of ligand. How-
ever, we cannot exclude the possibility that in the presence of
ligand the side chain of Tyr-372 may reposition. Thus, addi-
tional studies are needed to evaluate the role of this conserved
residue in the MPRs and GII.
Role of a Conserved Trp-409 among GIIMRHDomains—A
comparative analysis of the residues within and surrounding
the proposed binding pocket revealed another residue that is
highly conserved and unique to the GII MRH domain. Trp-
409, which is located in loop C, is absolutely conserved among
77 of the 79 homologs analyzed (Fig. 8) and is not present in the
other MRH domains (Fig. 2B). Our initial assessment of the
role of the conserved Trp-409 was performed in the context of
the isolated MRH domain. Mutants containing conservative
(W409F) or non-conservative (W409A) substitution of Trp-
409 were generated, and 15N-labeled proteins were evaluated.
15N-1H HSQC experiments show that both constructs are
folded, which is reflected in their similar 15N-1HHSQC spectra
as the wild-type protein (Fig. 9A). Furthermore, addition of 50
mM Man1,2Man disaccharide to the W409A 15N-labeled
sample resulted in chemical shift perturbations on the order of
those found for similar concentrations of the wild-type protein
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(Fig. 9B). In addition, SPR experiments show that W409A and
W409F bound immobilized glycoproteins bearing high man-
nose (Fig. 4A), phosphomonoesters (Fig. 4B), or phosphodi-
esters bearing a GlcNAc on the 6-OH group of the mannose
(Fig. 4C) with a slight decrease in affinity (within 3.5-fold) com-
paredwith thewild-type protein. Thus, substitution of Trp-409
does not dramatically lower binding affinity toward glycans in
the context of the isolated MRH domain.
To study the influence of Trp-409 of GIIMRH domain in
GII activity, we mutated Trp-409 in the full-length GII
(W409A or W409F), expressed the wild-type or mutated GII
in S. pombe cells lacking endogenous GII (GII), and mea-
suredGII activity toward both the small substrate analog pNPG
and [14C-Glc]Glc1Man9GlcNAc in microsomal fractions
obtained from the mutant cells. Results presented in Fig. 10A
show that although the influence of Trp-409 in GII-mediated
GII activity enhancement was not as strong asmutation of the
conserved residues (Gln, Arg, Glu, and Tyr) that interact with
the 2-, 3-, and 4-hydroxyl groups of the mannose ring (Fig. 2B),
mutation of Trp-409 precluded full GII activity toward N-gly-
cans in vitro. We have reported previously that microsomal GII
activity using pNPG reflects ERGII content (14). ReducedGII
activity observed in cells expressing Trp-409-mutated GII is
not due to a reduced ER GII content as the activity toward
pNPGwas not reduced inmutant GIIW409A orGIIW409F
(Fig. 10A). Moreover,Western blot analyses show normal GII
FIGURE 8. Close-up view of MRH binding pockets. The carbohydrate binding sites of GIIMRH domain (orange; Protein Data Bank code 2LVX), domain 3 of
CI-MPR (green; Protein Data Bank code 1SZ0), domain 5 of CI-MPR (blue; Protein Data Bank code 2KVB), OS-9 (gray; Protein Data Bank code 3AIH), and CD-MPR
(pink; Protein Data Bank code 1C39) show the four essential mannose-binding residues along with the proposed linkage-sensing Tyr or Trp. Modeled ligands
based on superimposition of the essential residues to a structure of known binding site (Man-6-P for GIIMRH domain andmethyl-Man-P-GlcNAc for CI-MPR
domain 5) are depicted in gray. Structures solved in the presence of bound ligands (Man-6-P for CI-MPR domain 3, Man1,6Man1,6Man for OS-9, and
pentamannosyl phosphate for CD-MPR) are shown in yellow. Loops C and D are labeled in all structures, and disulfide bridges are shown in yellow. Molecular
surfaces are shown over the ribbon schematic. A molecular surface of GII MRH domain colored by species conservation as determined by ConSurf is also
shown. Seventy-nine homologs were used in the calculation. Inspection of the GIIMRH domain 15N-1H HSQC spectra in the presence of increasing concen-
trations ofMan-6-P versusMan1,2Man revealed chemical shift perturbations consistent with location of themodeled ligandMan-6-P as amide chemical shift
changes in Gln-435 residing in loop D as well as Gly-411 in loop C were observed.
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levels in microsomes (enriched in ER membranes) obtained
from GII Trp-409 mutants (Fig. 10B).
To determine whether substitution of Trp-409 in the GII
MRH domain affects GII glucose trimming activity in vivo, we
analyzed the N-glycan pattern produced by GII cells
expressing Trp-409 GII mutants (W409A and W409F) and
compared it with theN-glycan patterns of cells expressingwild-
type GII or GIImutated in amino acids predicted to interact
with the mannose ring (Y439F and E433Q). Cells were incu-
bated with [14C]Glc for 15 min in the presence of 5 mM DTT,
and whole cell N-glycans were isolated and analyzed as
described under “Experimental Procedures.” The total incor-
poration of the label into the N-glycans was linear during the
incubation time, and the presence of DTT prevented the pas-
sage of glycoproteins to the Golgi, hindering further extension
of the recently synthesized N-glycans (46). The N-glycan pat-
terns obtained from S. pombe cells expressing wild-type GII
revealed that whereas deglucosylation of the transferred glycan
Glc3Man9GlcNac2 was so rapid that almost no glucose-con-
taining glycans were detected (Fig. 10C) the amount of gluco-
sylated glycans increased in cells expressing GII Trp-409
mutants, although it was not asmuch of an increase as observed
in the GII Y439F mutant (Fig. 10, D–F) and as observed pre-
viously inGIImutants (14). Taken together, the results dem-
onstrate that substitution of Trp-409 in the context of the full-
length GII has a moderate to high (60% inhibitory) effect on
GII activity.
How Does GIIMRH Domain Interact with High Mannose-
type Glycans?—Studies both in vitro and in vivo indicate that
residue k in armC plays amore significant role than residue i in
arm B of the glycan in the enhancement of GII catalytic activity
by GII (12–15). To envision how GII enhances the catalytic
activity of GII toward glycans, we propose two models that are
consistent with the existing biochemical and current structural
studies. In the first model, the terminal mannose (residue k) of
arm C is captured by the shallow binding pocket of the MRH
domain of GII defined by the four conserved residues (Gln-
384, Arg-414, Glu-433, and Tyr-439). Interaction of the termi-
nal mannose (residue i) of arm B with Trp-409 would further
constrain theN-glycan and facilitate optimal positioning of the
glucose-containing arm A near the catalytic site of GII (Fig.
11A). Visualization of this model was obtained by positioning
the terminal mannose residue of arm C of a Man9 glycan into
the MRH binding pocket from the superimposition of the four
mannose-binding essential residues (Gln-384, Arg-414, Glu-
433, and Tyr-439) with that of domain 3 of CI-MPR containing
bound Man-6-P (47). This overlay indicated that the terminal
mannose of arm B of the glycan is near loop C and that Trp-409
in loop C could stack against the terminal mannose ring of arm
B, thereby providing a bidentate mode of interaction between
the MRH domain and two arms of the glycan. Although a pre-
vious molecular dynamics simulation of a Man9GlcNAc2 gly-
can and NOE analyses indicate that significant flexibility of
arms A, B, and C of the glycan (48) complicates such analyses,
CH-	-mediated stacking interactions between aromatic resi-
dues and carbohydrates are commonly observed in lectins (49,
50), including another ER-resident lectin, malectin, that recog-
nizes the Glc1,3Glc moiety on Glc2-N-glycans (51). It is
intriguing to speculate that Trp-409 is located in a relatively
dynamic region of the GIIMRH domain (Fig. 5, A and C) to
capture one of themany and related conformers of anN-glycan.
In the second model (Fig. 11B), Trp-409 interacts with other
regions of the -subunit. Although the GII MRH domain
alone is sufficient for binding glycans, its affinity for ligandmay
be augmented by the presence of the remaining portion of the
-subunit and/or the -subunit. This enhancement in ligand
binding affinity has been reported for both domain 3 (52) and
domain 5 (26) of the CI-MPR. Trp-409 of GII could be posi-
tioned to interact with residues on adjacent parts of the holoen-
zyme and act to either stabilize the position of loops C and/or D
much like the linker region between domains 1 and 2 does for
domain 3 of CI-MPR, resulting in increased affinity for Man-
6-P (39, 47), or orient theMRHdomain closer toGII, resulting
FIGURE9.Comparisonof two-dimensionalHSQCspectraofwild-typeand
mutant recombinant GIIMRHdomain. A, overlay of 15N-1H HSQC spectra
from wild-type (black) or mutant (W409A, red; W409F, cyan) GII MRH
domain. B, overlay of 15N-1H HSQC spectra from wild-type (black) or mutant
(W409A, red) GII MRH domain in the absence of ligand. The 15N-1H HSQC
spectrum of W409A collected in the presence of 50 mM Man1,2Man disac-
charide is also shown (green).
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FIGURE 10. Influence of Trp-409 in GII-mediated GII activity enhancement toward N-glycans. A, GII activity toward pNPG or Glc1Man9GlcNAc was
measured in 125 g of microsomes from S. pombe cells lacking endogenous GII (GII) and expressing GII or the same subunit displaying the indicated
mutations. The activity ofGII cells transformedwithwild-typeGIIwas taken as 100%. Error bars represent S.D.B, GII ER contentwas evaluated.Microsomal
proteins (250g) of S. pombeGII,GII, orGII expressing exogenous variants of GIIwere resolved by 8% SDS-PAGE, transferred to a PVDFmembrane,
and blotted using mouse polyclonal anti-GII (1:500) or anti-GII (1:5000) subunit primary antibodies. Goat HRP anti-mouse IgG (1:5000) was used as the
secondary antibody. Reactions were detected by chemiluminescence. Because endogenous GII levels are significantly lower than exogenously expressed
levels, theGIIbandwasdetected in theGIImutant (middle lane;GII) only uponoverexposing theblot.C–F, glycanpatterns synthesizedby S. pombeGII
mutant cells expressing GII (C) or mutated GII versions (D and E). Endoplasmic reticulum N-glycans produced by GII cells expressing GIIW409A were
indistinguishable from those produced by cells expressing GII W409F. The N-glycan pattern produced by GII cells expressing GII E433Q was indistin-
guishable from that of the same cells expressing GII Y439F. Quantification of the relative amounts of the di-, mono-, and unglucosylated species in each
mutant is shown in F. The label of Man8 species was added to that in Man9 species to account for unglucosylated glycans.
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in arm A of the glycan becoming optimally positioned into the
catalytic site. Both models indicate that the active site of GII
must be very close to that of the binding pocket of the MRH
domain of GII. In comparison with the other MRH domains,
the shorter loops between strands 2 and 3 and strands 4/5 and 6
along with shorter strands 4/5 and 6 (Fig. 5D) may allow a close
juxtapositioning of the catalytic site with the MRH domain.
Concluding Remarks—In the current study, we have deter-
mined the solution structure of the S. pombe GII MRH
domain, and its function was characterized alone and in the
context of the full-length GII subunit. This is the first time
that the structure of an MRH domain of an enzyme has been
determined. The structure reveals the conserved MRH fold
observed in theMPRs (35, 39–42) andOS-9 (7), but in contrast
to these proteins, GIIMRH domain contains a shallow bind-
ing pocket that accommodates only a single mannose residue.
In addition, we have identified a conserved residue, Trp-409,
that plays an important role in GII glucose trimming activity in
vivo. Additional structural studies are needed to fully under-
stand how this heterodimeric enzyme interacts withN-glycans
and thus regulates the quality control of glycoprotein folding in
the ER.
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